Amryt Pharma (AMYT) Short Interest Ratio & Short Volume

Short interest is the volume of Amryt Pharma shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 229,500 shares of AMYT short. Learn More on Amryt Pharma's current short interest.

Amryt Pharma saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 229,500 shares, an increase of 89.4% from the previous total of 121,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Amryt Pharma: Perrigo Company plc (3.85%), Akero Therapeutics, Inc. (10.55%), Ultragenyx Pharmaceutical Inc. (6.28%), Zai Lab Limited (8.24%), Viking Therapeutics, Inc. (23.97%), Crinetics Pharmaceuticals, Inc. (11.29%), PTC Therapeutics, Inc. (6.87%), Catalyst Pharmaceuticals, Inc. (7.55%), Merus (9.03%), Xenon Pharmaceuticals Inc. (5.51%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.66 billion), TC Energy Co. ($4.13 billion), Occidental Petroleum Co. ($3.04 billion), Moderna, Inc. ($2.63 billion), Coinbase Global, Inc. ($2.51 billion), T. Rowe Price Group, Inc. ($2.29 billion), Paramount Global ($2.26 billion), Verisk Analytics, Inc. ($2.19 billion), Etsy, Inc. ($1.84 billion), and Voya Financial, Inc. ($1.67 billion). View all of the most shorted stocks.

Short selling AMYT is an investing strategy that aims to generate trading profit from Amryt Pharma as its price is falling. AMYT shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Amryt Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AMYT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AMYT, twice per month. The most recent reporting period available is March, 31 2023.